Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2025-12-24 @ 7:16 PM
NCT ID:
NCT04415203
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed as frequent premature ventricular contractions;
* 2 ≤ Lown level ≤ 4A;
* 18 ≤ age ≤ 75;
* Volunteered to participant
Exclusion Criteria:
* Severe valvular disease, congenital heart disease, pericardial disease, hypertrophic cardiomyopathy, unstable angina pectoris, acute myocardial infarction, myocarditis, aneurysm, congestive heart failure decompensation period (NYHA grade III or VI), cardiogenic shock, cerebrovascular disease, hematopoietic system disease, severe mental disease;
* Bradycardia, including pathologic sinus node syndrome, degree II or greater atrioventricular block;
* Those who have already had pacemaker or percutaneous coronary intervention, or who plan to have pacemaker or percutaneous coronary intervention;
* Pregnant or lactating women;
* Local sensory deficit, or allergic to current;
* May be allergic to percutaneous patches；
* Blood pressure ≤ 90/60 mmHg;
* Those who have participated in other clinical trials within 3 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04415203
Study Brief:
Protocol Section:
NCT04415203